Rick Claypool on Pay to Play Corporate Crime Enforcement 
Labaton Launches Whistleblower Practice with Former SEC Acting Chair Allison Herren Lee 
Kremlin payment firm A7 has been pumping billions in ‘untraceable’ cash into global financial system The World Health Organization announced on Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease.
“The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy,” the WHO said in a statement.
Advertisement
Up to now, infants have been treated with formulations intended for older children – carrying a greater risk of dosage errors, side effects and toxicity.
“For centuries, malaria has stolen children from their parents, and health, wealth and hope from communities,” WHO chief Tedros Adhanom Ghebreyesus said.
“But today, the story is changing. New vaccines, diagnostic tests, next-generation mosquito nets and effective medicines, including those adapted for the youngest, are helping to turn the tide.
Advertisement
Don't Miss:
-
A Total of 13 Mass Graves Have Been Found in Viesca Containing the Charred Remains of Men and Women
-
Jorge Luis Zambrano, alias “Rasquiña”
-
El Taliban Fell In Mazatlán… And What He Confessed Ties Everything Together
-
Inside the Camp at the Heart of Honduras’ Garífuna Land Struggle
-
This Is How the MataZetas Captured and Executed the Zetas